Guaifenesin And Dextromethorphan Hbr Tablet, Extended Release
Product Images NDC 51660-301

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Dextromethorphan Hbr (NDC 51660-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ohm Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (20 Tablet Blister Pack Carton)

Packaging label for Guaifenesin and Dextromethorphan HBr extended-release tablets, containing 600 mg of Guaifenesin and 30 mg of Dextromethorphan HBr per tablet. The front panel highlights 40 extended-release tablets designed as an expectorant and cough suppressant with 12-hour relief. The labeler is OHM Laboratories Inc. The box includes usage claims such as controlling cough and thinning mucus, plus directions and warnings on the side and back panels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.